Kilitch Drugs (India) Limited

KILITCH

INE729D01010

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:54 28/06/2024 pm IST			5-day change	1st Jan Change
335.4 ^INR	-2.71%		+2.88%	-9.78%

27/05	Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
26/02	Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia	MT

Kilitch Drugs Limited Announces Resignation of Shailesh Mirgal as Chief Financial Officer

May 04, 2019

Kilitch Drugs (India) Limited announced that Mr. Shailesh Mirgal has resigned from the post of Chief Financial Officer of the company with effect from 4 February, 2019.

Latest news about Kilitch Drugs (India) Limited

Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	27/05	CI
Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia	26/02	MT
Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals	23/02	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29	CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/23/29	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/22/10	CI
Kilitch Drugs Limited Announces Management Changes	27/22/27	CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	26/22/26	CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	26/22/26	CI
Bhavin Mehta completed the acquisition of 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.	22/22/22	CI
Kilitch Drugs Limited Announces Resignation of Princy Asati as Company Secretary & Compliance Officer	15/22/15	CI
Bhavin Mehta agreed to acquire 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.	12/22/12	CI
Kilitch Drugs Limited Commences New Facility Expansion Plan	04/22/04	CI
Kilitch Drugs (India) to Build Pharma Complex in Khopoli, India	03/22/03	MT
Kilitch Drugs Limited Announces Expansion of Manufacturing Facility at Khopoli	03/22/03	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/22/14	CI
Kilitch Drugs Limited announced that it expects to receive INR 22.14375 million in funding	20/21/20	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Kilitch Drugs Limited Announces Executive Changes	13/21/13	CI
Kilitch Drugs India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/21/13	CI

Chart Kilitch Drugs (India) Limited

Duration

Period

More charts

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Companyâs products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KILITCH DRUGS (INDIA) LIMITED	-9.78%	64.71M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B